Haffkine Biopharma to produce 22.8 cr doses of Covaxin per annum

New Delhi, June 2  The Centre on Wednesday took steps to accelerate domestic vaccine production. Mumbai-based Haffkine Biopharma will produce 22.8 crore doses per annum of Covaxin under technology transfer arrangement with Bharat Biotech. With the aim of vaccinating the